CABA analyst estimates
Cabaletta Bio (CABA) analyst ratings, the average price target and its range, and every firm's latest call.
CABA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Mar 21, 2024 | Stifel Nicolaus | Cabaletta Bio Inc. (CABA) PT Raised to $32 at Stifel | $32.00 |
| Jan 3, 2023 | Wells Fargo | Wells Fargo Maintains Overweight on Cabaletta Bio, Raises Price Target to $14 | $14.00 |
| Aug 30, 2022 | Morgan Stanley | Cabaletta Bio downgraded to Equal Weight from Overweight at Morgan Stanley | $3.00 |
- 6 firms rate CABA: 5 buy, 1 hold, 0 sell.
- The average price target is $16.33 from None analysts, from $3.00 to $32.00.
Updated 2026-11-10 04:45 UTC